Seriously, thank you to everyone who joined early and helped get this community off the ground. If you’re one of the first 50 members, you’re locked in for free. That was the promise from the beginning, and we’re keeping it. Going forward, new members will be joining at $9/month as we keep adding more vendor research, COAs, guides, price comparisons, and new resources. Really appreciate everyone who’s been active, asking questions, sharing experiences, and helping make this place better. We’re just getting started.

Since you’re here early, introduce yourself below 👇 Where are you from? 🌎 What got you interested in peptides? 🧬 What do you want to learn more about? 🤔 I’ll start — I’m Dave, and I created Peps by Dave to make peptide research simpler and help people stop overpaying. Your turn 👇

Welcome to Peps by Dave! I created this community because peptides can be confusing, expensive, and full of conflicting information. Our goal is simple: 🧪 Make peptide research easy to understand 🔬 Break down the science in plain English 💰 Help you avoid overpaying and costly mistakes 🧾 Understand testing, COAs, and quality 🤝 Build a community where people actually help each other 🚀 WHAT TO EXPECT We’re just getting started, and you’re here early. As we grow, expect: • Simple peptide breakdowns • Research & study summaries • Testing & COA education • Vendor & quality research • Price comparisons & ways to save • Community Q&As and discussions We’ll cover BPC-157, Retatrutide, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Semax, Selank, NAD+ and more. 📋 COMMUNITY RULES 1. Be respectful — different opinions are welcome. 2. No spam, selling, or random promotions. 3. Share research and experiences, not medical advice. 4. Question everything — look at the evidence and do your own research. ⚠️ IMPORTANT Peps by Dave is for education and discussion only. Nothing here should be considered medical advice, diagnosis, or treatment recommendations. Ask questions. Share what you learn. Help others when you can. Research more. Understand quality. Spend smarter. Welcome to Peps by Dave. 🧬 — Dave

- Epithalon targets telomerase activation and melatonin restoration — a speculative longevity approach with a single-lab evidence base. - SS-31 (Elamipretide) targets cardiolipin stabilization in the mitochondrial inner membrane — an FDA-approved therapy (Barth syndrome, September 2025) with Phase 2/3 clinical trial data. - These are complementary mechanisms: one addresses chromosomal aging (telomeres), the other addresses cellular energy aging (mitochondria). - SS-31 has substantially stronger independent evidence; Epithalon has intriguing mechanistic theory but requires caution around evidence quality.

What the clinical trial results actually showed